A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Name: A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
License: Public Domain

Pfizer

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

macular edema associated with diabetes mellitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261415
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.